MedPath

PROLIA

PROLIA

Approved
DIN Number

02343541

Drug Class

Human

Market Date

Aug 12, 2010

Company
HC

Amgen Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02343541
AIG Number0152691001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
M05BX04 DENOSUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:16.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DENOSUMABActive
Strength: 60 MG / ML
Monograph: DENOSUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.